These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 1761919)
1. [Cytokines and diseases. Abnormal expression of interleukin 6 and diseases]. Hirano T Nihon Naika Gakkai Zasshi; 1991 Sep; 80(9):1401-8. PubMed ID: 1761919 [No Abstract] [Full Text] [Related]
2. Interleukin 6 (IL-6) and its receptor (IL-6R) in myeloma/plasmacytoma. Suematsu S; Hibi M; Sugita T; Saito M; Murakami M; Matsusaka T; Matsuda T; Hirano T; Taga T; Kishimoto T Curr Top Microbiol Immunol; 1990; 166():13-22. PubMed ID: 2073791 [No Abstract] [Full Text] [Related]
10. Interleukin 6 (IL-6) and its receptor: their role in plasma cell neoplasias. Hirano T Int J Cell Cloning; 1991 May; 9(3):166-84. PubMed ID: 2061619 [TBL] [Abstract][Full Text] [Related]
11. Interleukin 6 and autoimmunity and plasma cell neoplasias. Hirano T Res Immunol; 1992 Sep; 143(7):759-63. PubMed ID: 1439152 [No Abstract] [Full Text] [Related]
12. Human mesangial cell-derived interleukin 8 and interleukin 6: modulation by an interleukin 1 receptor antagonist. Brown Z; Fairbanks L; Strieter RM; Neild GH; Kunkel SL; Westwick J Adv Exp Med Biol; 1991; 305():137-45. PubMed ID: 1836711 [No Abstract] [Full Text] [Related]
13. [Hepatitis C and immunologic anomalies]. Lunel F Gastroenterol Clin Biol; 1994; 18(10):829-38. PubMed ID: 7875390 [No Abstract] [Full Text] [Related]
14. Involvement of IL-6 in mesangial proliferative glomerulonephritis. Horii Y; Muraguchi A; Iwano M; Matsuda T; Hirayama T; Yamada H; Fujii Y; Dohi K; Ishikawa H; Ohmoto Y J Immunol; 1989 Dec; 143(12):3949-55. PubMed ID: 2592764 [TBL] [Abstract][Full Text] [Related]
15. [The importance of interleukin 6 (IL-6) in pathogenesis and diagnosis of renal glomerular diseases]. Kacprzyk F Postepy Hig Med Dosw; 1995; 49(4):513-22. PubMed ID: 8657645 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic effect of cytomedicine on mesangio-proliferative glomerulonephritis in human interleukin-6 transgenic mice. Okada N; Miyamoto H; Yoshioka T; Katsume A; Saito H; Yorozu K; Ueda O; Nakagawa S; Ohsugi Y; Mayumi T Biol Pharm Bull; 1997 Mar; 20(3):255-8. PubMed ID: 9084882 [TBL] [Abstract][Full Text] [Related]
17. Chronic thrombopoietin overexpression induces mesangioproliferative glomerulopathy in mice. Shimoda HK; Yamamoto M; Shide K; Kamezaki K; Matsuda T; Ogawa K; Harada M; Shimoda K Am J Hematol; 2007 Sep; 82(9):802-6. PubMed ID: 17546634 [TBL] [Abstract][Full Text] [Related]
18. Platelet-derived growth factor and proliferative glomerulonephritis. Gesualdo L; Ranieri E; Pannarale G; Di Paolo S; Schena FP Kidney Int Suppl; 1993 Jan; 39():S86-9. PubMed ID: 8468932 [No Abstract] [Full Text] [Related]
19. [Pathogenesis of rat mesangial proliferative glomerulonephritis induced by anti-Thy1 antibody]. Zhang KF; Zhang L; Wu XF; Zhang XG; Yu H; Zhao SQ Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):188-90. PubMed ID: 15071912 [TBL] [Abstract][Full Text] [Related]
20. Hepatocellular hyperplasia, plasmacytoma formation, and extramedullary hematopoiesis in interleukin (IL)-6/soluble IL-6 receptor double-transgenic mice. Schirmacher P; Peters M; Ciliberto G; Blessing M; Lotz J; Meyer zum Büschenfelde KH; Rose-John S Am J Pathol; 1998 Aug; 153(2):639-48. PubMed ID: 9708822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]